Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-02 Sale | 2023-03-03 4:31 pm | Kymera Therapeutics Inc. | KYMR | Caughey Elaine Chief Business Officer | 714 | $31 | $22,132 | 82,324 (Direct) | View |
| 2023-03-02 Sale | 2023-03-03 4:30 pm | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 1,298 | $31 | $40,233 | 187,209 (Direct) | View |
| 2023-03-02 Sale | 2023-03-03 4:30 pm | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 1,370 | $31 | $42,465 | 247,068 (Direct) | View |
| 2023-01-11 Purchase | 2023-01-13 5:08 pm | Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks and Footnotes | 41,007 | $30.51 | $1,251,191 | 2,218,295 (Indirect Direct) | View |
| 2023-01-11 Sale | 2023-01-13 4:53 pm | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 126,474 | $30.22 | $3,821,739 | 890,148 (Indirect) | View |
| 2023-01-11 Sale | 2023-01-13 4:50 pm | Kymera Therapeutics Inc. | KYMR | Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner | 126,474 | $30.22 | $3,821,739 | 5,858,262 (Indirect Direct) | View |
| 2022-12-14 Sale | 2022-12-16 5:05 pm | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 382,244 | $31.36 | $11,985,954 | 917,811 (Indirect) | View |
| 2022-12-14 Sale | 2022-12-16 5:03 pm | Kymera Therapeutics Inc. | KYMR | Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner | 382,244 | $31.36 | $11,985,954 | 5,984,736 (Indirect Direct) | View |
| 2022-11-02 Sale | 2022-11-04 4:31 pm | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 220,016 | $30.01 | $6,602,952 | 1,001,417 (Indirect) | View |
| 2022-11-02 Sale | 2022-11-04 4:30 pm | Kymera Therapeutics Inc. | KYMR | Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner | 220,016 | $30.01 | $6,602,952 | 6,366,980 (Indirect Direct) | View |
| 2022-10-28 Sale | 2022-11-01 7:36 pm | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 288,702 | $30.26 | $8,735,143 | 1,049,540 (Indirect) | View |
| 2022-10-28 Sale | 2022-11-01 7:34 pm | Kymera Therapeutics Inc. | KYMR | Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner | 288,702 | $30.26 | $8,735,143 | 6,586,996 (Indirect Direct) | View |
| 2022-08-22 Purchase | 2022-08-23 5:35 pm | Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks and Footnotes | 545,525 | $26 | $14,183,650 | 329,944 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-08-08 Exercise | 2023-08-08 4:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 12,000 | $2.08 | 588,938 (Direct) | View |
| 2023-08-08 Exercise | 2023-08-08 4:30 pm | N/A 2029-05-22 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 12,000 | $0 | 588,938 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 5:55 pm | N/A 2033-06-14 | Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks and Footnotes | 12,000 | $0 | 4,724,983 (Indirect) | View |
| 2023-06-15 Option Award | 2023-06-20 4:16 pm | N/A 2033-06-14 | Kymera Therapeutics Inc. | KYMR | Sandor Victor Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 4:15 pm | N/A 2033-06-14 | Kymera Therapeutics Inc. | KYMR | Morgan Leigh Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 4:15 pm | N/A 2033-06-14 | Kymera Therapeutics Inc. | KYMR | MARAGANORE JOHN Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 4:15 pm | N/A 2033-06-14 | Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 4:15 pm | N/A 2033-06-14 | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 4:15 pm | N/A 2033-06-14 | Kymera Therapeutics Inc. | KYMR | Horobin Joanna Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 4:15 pm | N/A 2033-06-14 | Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 4:15 pm | N/A 2033-06-14 | Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 4:15 pm | N/A 2033-06-14 | Kymera Therapeutics Inc. | KYMR | Hrustanovic Gorjan Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2023-06-02 Exercise | 2023-06-02 2:17 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $2.08 | 244,934 (Direct) | View |
| 2023-06-02 Exercise | 2023-06-02 2:17 pm | N/A 2029-08-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $0 | 244,934 (Direct) | View |
| 2023-05-22 Option Award | 2023-05-22 7:35 pm | N/A 2023-05-22 | Kymera Therapeutics Inc. | KYMR | Chadwick Jeremy G Chief Operating Officer | 233,333 | $0 | 233,333 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 4:31 pm | N/A 2033-02-28 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 450,000 | $0 | 450,000 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 4:31 pm | N/A 2033-02-28 | Kymera Therapeutics Inc. | KYMR | Caughey Elaine Chief Business Officer | 73,895 | $0 | 82,324 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 4:30 pm | N/A 2033-02-28 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 131,250 | $0 | 187,209 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 4:30 pm | N/A 2033-02-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 166,250 | $0 | 247,068 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 4:35 pm | N/A 2033-01-02 | Kymera Therapeutics Inc. | KYMR | Chiniara Ellen Chief Legal Officer | 262,500 | $0 | 262,500 (Direct) | View |
| 2022-12-08 Exercise | 2022-12-08 6:11 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 10,000 | $2.08 | 592,425 (Direct) | View |
| 2022-12-08 Exercise | 2022-12-08 6:11 pm | N/A 2029-11-13 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 10,000 | $0 | 592,425 (Direct) | View |
| 2022-11-03 Option Award | 2022-11-03 7:22 pm | N/A 2032-11-02 | Kymera Therapeutics Inc. | KYMR | Sandor Victor Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2022-10-21 Exercise | 2022-10-24 08:00 am | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $2.08 | 221,178 (Direct) | View |
| 2022-10-21 Exercise | 2022-10-24 08:00 am | N/A 2029-08-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $0 | 221,178 (Direct) | View |
| 2022-10-17 Exercise | 2022-10-17 8:12 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $2.08 | 221,178 (Direct) | View |
| 2022-10-17 Exercise | 2022-10-17 8:12 pm | N/A 2029-08-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $0 | 221,178 (Direct) | View |
| 2022-10-17 Exercise | 2022-10-17 8:09 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 59,732 | $2.08 | 1,122,903 (Direct) | View |
| 2022-10-17 Exercise | 2022-10-17 8:09 pm | N/A 2029-05-22 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 59,732 | $0 | 1,122,903 (Direct) | View |
| 2022-07-06 Option Award | 2022-07-08 4:10 pm | N/A 2032-07-05 | Kymera Therapeutics Inc. | KYMR | Morgan Leigh Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2022-06-29 Option Award | 2022-07-01 4:05 pm | N/A 2032-06-28 | Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 7:20 pm | N/A 2032-06-14 | Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks and Footnotes | 12,000 | $0 | 4,126,451 (Indirect) | View |